Omeros OMER
NASDAQ OMER
$18.61 +0.14 (+0.76%)
At close: Oct 2, 2026 · 4:00 PM EDT

Omeros (OMER) Price to Sales (2011 - 2026)

Updated

Omeros' Price to Sales came in at 17.84 for Q2 2026, up 482.9% from 3.06 a year earlier but down 6.4% from the prior quarter.

Analysis

Omeros (OMER) Price to Sales (2011 - 2026) Analysis & Trends

For FY2020, Omeros' Price to Sales was 11.94, up 74.8% from FY2019.

  • Going back by year, Price to Sales was 6.83 in FY2019 (-62.6%), 18.28 in FY2018 (+26.5%), 14.45 in FY2017 (+38.3%) and 10.44 in FY2016 (-76.4%).
  • The five-year range for quarterly Price to Sales is 3.06 (Q2 2025) to 19.06 (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Omeros 1.34 Bn 1.34 Bn 27.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.84
Mar 31, 2026 19.06
Jun 30, 2025 3.06
Mar 31, 2025 5.97
Sep 30, 2021 9.53
Jun 30, 2021 10.70
Mar 31, 2021 15.53
Dec 31, 2020 11.94
Sep 30, 2020 6.45
Jun 30, 2020 8.00
Mar 31, 2020 6.42
Dec 31, 2019 6.83
Sep 30, 2019 8.05
Jun 30, 2019 10.27
Mar 31, 2019 17.01
Dec 31, 2018 18.28
Sep 30, 2018 55.38
Jun 30, 2018 22.76
Mar 31, 2018 9.96
Dec 31, 2017 14.45
API Access

Omeros Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=OMER&period=max&api_key=YOUR_API_KEY